|Bid||59.00 x 120500|
|Ask||61.50 x 593600|
|Day's range||59.00 - 60.00|
|52-week range||40.00 - 175.00|
|Beta (3Y monthly)||1.10|
|PE ratio (TTM)||N/A|
|Earnings date||4 Mar 2019 - 8 Mar 2019|
|Forward dividend & yield||N/A (N/A)|
|1y target est||277.00|
Anyone researching Silence Therapeutics plc (LON:SLN) might want to consider the historical volatility of the share price. Modern finance theory considers volatility to be a measure of risk, and there Read More...
Silence Therapeutics advances next RNAi medicine Lipoprotein(a) targeting, an exciting approach to address cardiovascular disease
In this article, I will take a quick look at Silence Therapeutics plc’s (LON:SLN) recent ownership structure – an unconventional investing subject, but an important one. A company’s ownership structureRead More...